Avricore Health Inc. (FRA:8VP1)

Market Cap	3.13M
Revenue (ttm)	1.92M
Net Income (ttm)	-891.49K
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0250
Previous Close	0.0280
Day's Range	0.0250 - 0.0250
52-Week Range	0.0195 - 0.0490
Beta	n/a
RSI	52.01
Earnings Date	Nov 28, 2025

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8VP1

Financial Performance

In 2024, Avricore Health's revenue was 4.79 million, an increase of 37.32% compared to the previous year's 3.49 million. Losses were -668,977, -4.60% less than in 2023.

Financial numbers in CAD